methyldopa has been researched along with Infant, Small for Gestational Age in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellos, I; Daskalakis, G; Loutradis, D; Papapanagiotou, A; Pergialiotis, V | 1 |
| Ahmed, B; Havard, A; Jorm, LR; Kennedy, SE; Tran, DT; Zoega, H | 1 |
| Guo, Y; Krewski, D; Mattison, D; Nerenberg, K; Walker, MC; Wen, SW; Xie, RH | 1 |
| Jabeen, F; Malik, AR; Mir, S; Molvi, SN; Rana, VS | 1 |
| Clairambault, J; Curzi-Dascalova, L; Eiselt, M; Kauffmann, F; Médigue, C; Peirano, P; Spassov, L | 1 |
1 review(s) available for methyldopa and Infant, Small for Gestational Age
| Article | Year |
|---|---|
Comparative efficacy and safety of oral antihypertensive agents in pregnant women with chronic hypertension: a network metaanalysis.
Topics: Abruptio Placentae; Amlodipine; Antihypertensive Agents; Atenolol; Cesarean Section; Chronic Disease; Female; Fetal Growth Retardation; Furosemide; Gestational Age; Humans; Hypertension; Incidence; Infant, Small for Gestational Age; Ketanserin; Methyldopa; Network Meta-Analysis; Nifedipine; Perinatal Death; Pindolol; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Premature Birth; Severity of Illness Index | 2020 |
1 trial(s) available for methyldopa and Infant, Small for Gestational Age
| Article | Year |
|---|---|
Role of antihypertensive therapy in mild to moderate pregnancy-induced hypertension: a prospective randomized study comparing labetalol with alpha methyldopa.
Topics: Adult; Antihypertensive Agents; Cesarean Section; Female; Humans; Hypertension, Pregnancy-Induced; Incidence; Infant, Newborn; Infant, Small for Gestational Age; Labetalol; Methyldopa; Pregnancy; Premature Birth; Proteinuria; Severity of Illness Index; Treatment Outcome; Young Adult | 2012 |
3 other study(ies) available for methyldopa and Infant, Small for Gestational Age
| Article | Year |
|---|---|
Maternal and perinatal outcomes associated with the use of renin-angiotensin system (RAS) blockers for chronic hypertension in early pregnancy.
Topics: Adult; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cesarean Section; Cohort Studies; Female; Humans; Hypertension; Infant, Low Birth Weight; Infant, Newborn; Infant, Small for Gestational Age; Methyldopa; Pregnancy; Pregnancy Trimester, First; Premature Birth | 2018 |
Beta-blockers increase the risk of being born small for gestational age or of being institutionalised during infancy.
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Female; Hospitalization; Humans; Hypertension; Hypertension, Pregnancy-Induced; Infant, Newborn; Infant, Small for Gestational Age; Logistic Models; Methyldopa; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Retrospective Studies; Risk Factors; Saskatchewan; Treatment Outcome | 2014 |
Heart rate and heart rate variability during sleep in small-for-gestational age newborns.
Topics: Basal Metabolism; Birth Weight; Female; Fetal Growth Retardation; Gestational Age; Heart Rate; Humans; Hypertension; Infant, Newborn; Infant, Small for Gestational Age; Labetalol; Male; Methyldopa; Pregnancy; Pregnancy Complications, Cardiovascular; Sleep | 1994 |